Atrys Health Price To Book vs. Current Valuation

ATRY Stock  EUR 3.00  0.05  1.64%   
Considering the key profitability indicators obtained from Atrys Health's historical financial statements, Atrys Health SL may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Atrys Health's ability to earn profits and add value for shareholders.
For Atrys Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Atrys Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Atrys Health SL utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Atrys Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Atrys Health SL over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Atrys Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atrys Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atrys Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Atrys Health SL Current Valuation vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Atrys Health's current stock value. Our valuation model uses many indicators to compare Atrys Health value to that of its competitors to determine the firm's financial worth.
Atrys Health SL is rated fourth in price to book category among its peers. It also is rated fourth in current valuation category among its peers reporting about  504,413,714  of Current Valuation per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Atrys Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Atrys Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Atrys Current Valuation vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Atrys Health

P/B

 = 

MV Per Share

BV Per Share

 = 
1.28 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Atrys Health

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
647.57 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Atrys Current Valuation vs Competition

Atrys Health SL is rated fourth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is presently estimated at about 4.4 Billion. Atrys Health retains roughly 647.57 Million in current valuation claiming about 15% of stocks in Biotechnology industry.

Atrys Health Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Atrys Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Atrys Health will eventually generate negative long term returns. The profitability progress is the general direction of Atrys Health's change in net profit over the period of time. It can combine multiple indicators of Atrys Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 525 people.

Atrys Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Atrys Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Atrys Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Atrys Health's important profitability drivers and their relationship over time.

Use Atrys Health in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atrys Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atrys Health will appreciate offsetting losses from the drop in the long position's value.

Atrys Health Pair Trading

Atrys Health SL Pair Trading Analysis

The ability to find closely correlated positions to Atrys Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atrys Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atrys Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atrys Health SL to buy it.
The correlation of Atrys Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atrys Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atrys Health SL moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atrys Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Atrys Health position

In addition to having Atrys Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Military Industrial Thematic Idea Now

Military Industrial
Military Industrial Theme
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Atrys Stock

To fully project Atrys Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Atrys Health SL at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Atrys Health's income statement, its balance sheet, and the statement of cash flows.
Potential Atrys Health investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Atrys Health investors may work on each financial statement separately, they are all related. The changes in Atrys Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Atrys Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.